Articles related to COVID-19

Genomic analyses revealed that all circulating strains were descendants of the Omicron JN.1 variant, “representing the first season without a SARS-CoV-2 strain replacement since the beginning of the COVID-19 pandemic.”

Dr. Joseph Wu, the study’s lead author and director of the Stanford Cardiovascular Institute: “These two cytokines cause inflammation to the blood vessels. They could cause inflammation to the heart.”

Pharmacists’ ability to provide off-label vaccines may be severely constrained… IDSA calls on insurers to continue covering COVID vaccines consistent with multiple medical society recommendations.

The more targeted vaccine formulation allows for administration of a smaller mRNA dose (10 mcg/0.2 mL) while achieving “higher seroresponse rates and geometric mean neutralizing antibody titer levels.”

Higher vaccine efficacy (13.5% [95% CI, -7.7, 30.6]) was observed with mNexspike vs the comparator in individuals aged 65 years and older.

Future monitoring of VE is required to support ongoing policy decisions around the implementation of COVID-19 vaccines.